Work

MUC1 Inhibition Reverses the Poor Immunogenicity of Leukemia Stem Cells Rendering Them Susceptible to Immunotherapy

Year: 2011

Type: article

Source: Blood

DOI: 10.1182/blood.v118.21.1883.1883

Authors: Dina Stroopinsky, Jacalyn Rosenblatt, Heidi Mills, Katarina Luptakova, Brett Glotzbecker, Baldev Vasir, Robin Joyce, James Levine, Dimitrios Tzachanis, Jon E. Arnason, Ilene Galinsky, Richard M. Stone, Donald Kufe, Yoram Reiter, David Avigan

Institutions: Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Technion – Israel Institute of Technology

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594713144

FWCI: 0.141

Cites:

Cited by: 1

Related to: 10